Skip to main content
. Author manuscript; available in PMC: 2010 Dec 9.
Published in final edited form as: Arch Gen Psychiatry. 2010 Aug;67(8):793–802. doi: 10.1001/archgenpsychiatry.2010.90

Figure 3.

Figure 3

Proportion of responders and remitters after ketamine or placebo infusion by Montgomery-Asberg Depression Rating Scale (MADRS) score. A, Proportion of responders (50% improvement on MADRS) from 40 minutes to day 14 postinfusion (n=18). B, Proportion of remitters (MADRS score <10) from 40 minutes to day 14 postinfusion (n=18).